Portishead, UK

IQVIA Laboratories’ Portishead facility delivers comprehensive drug discovery services across immunology, immuno-oncology, inflammation, and infectious diseases. The site supports preclinical development from advanced cell biology through efficacy modeling to clinical sample analysis.

Website Featured Image_PNG-3701_Custom Photo_Laboratory professionals

Comprehensive Drug Discovery Expertise in Portishead

Founded as KWS BioTest in 2004, the Portishead, UK location, formally Charles River Portishead, was acquired by IQVIA Laboratories in 2026 to expand our drug discovery offering. The facility spans 22,500 square feet and includes specialized laboratories and two distinct vivaria dedicated to immunology and infectious disease research. The site provides integrated support for preclinical development, emphasizing precision and scientific rigor, with approximately 75 full-time employees, 65% of whom hold advanced degrees.

Laboratory Details

Approximately 22,500 square feet
In vivo rodent models
Two distinct vivaria: immunology unit and infection unit
Analytical laboratories
Tissue culture laboratories

Service Areas and Study Types

Immuno-oncology
Infectious diseases: viral and bacterial
Immunology and autoimmune disease
Inflammation and allergy
Neuroinflammation
In vivo pharmacology
Cell biology and bioanalytical services
Flow cytometry core facility (FACS sorter and analyzers)
Gene expression analysis
Clinical biomarkers
Predictive immunotoxicology

Certifications

Our Portishead facility operates in compliance with the requirements of the following regulatory agencies or accredited organizations

GCLP
AAALAC
MGL (MyGreenLab)